| Posts by mikehunt2 |
| Message | Subject | Recs | Posted |
| Arrowhead Announces FDA Clearance to Initiate AdipotideTM Phase I Clinical T | Arrowhead Resarch | | 1/4/2012 |
| NISSHA PRINTING : Announcement of Joint Development Agreement with Unidym, Inc | Arrowhead Resarch | | 12/6/2011 |
| Arrowhead Research Subsidiary Ablaris Therapeutics Data Published in Science T | Arrowhead Resarch | 1 | 11/10/2011 |
| Arrowhead Research Publishes White Paper on RNAi Delivery Technology Acquired f | Arrowhead Resarch | | 11/7/2011 |
| Vascular Research Further Validates the Drug Development Programs of Arrowhea | Arrowhead Resarch | | 11/2/2011 |
| Arrowhead Research Corporation Acquires Roche RNA Assets and Site Three New | Arrowhead Resarch | | 10/24/2011 |
| Cerulean Pharma Doses First Patients in Randomized Phase 2 Clinical Study of CRL | Arrowhead Resarch | 1 | 7/13/2011 |
| Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an O | Telos (TLSRP) preferred | | 7/8/2011 |
| Arrowhead Research Corporation (NASDAQ:ARWR - News), a nanomedicine company with | Arrowhead Resarch | | 4/6/2011 |
| -1, Telos Can Compete for Air Employee Security Work, TSA Says 2011-02-25 19:08: | Telos (TLSRP) preferred | | 2/25/2011 |
| Telos Leads NETCENTS Primes For Q4 FY2010 Company’s New Awards Total More Than $ | Telos (TLSRP) preferred | | 2/22/2011 |
| Even better Arrowhead Subsidiary Unidym, Inc. Acquired by Wisepower Co., Ltd. fo | Arrowhead Resarch | | 1/18/2011 |
| Arrowhead Starts New Subsidiary, Ablaris Therapeutics, to Commercialize Anti-Obe | Arrowhead Resarch | | 12/20/2010 |
| Arrowhead CEO Provides Perspective on $4.5 million Alliance Between Subsidiary U | Arrowhead Resarch | | 12/9/2010 |
| Telos ID Partners with Inquiries Inc. to Create IDVetting EASTON, Md. & A | Telos (TLSRP) preferred | | 7/20/2010 |
| Arrowhead Portfolio Company, Leonardo Biosystems, Receives $2.5 Million Funding | Arrowhead Resarch | | 6/7/2010 |
| Unidym and Tokyo Electron Begin Joint Program to Develop Large Scale Manufacturi | Arrowhead Resarch | | 6/4/2010 |
| Arrowhead Research Announces Clinical Data Presentations at the 2010 ASCO Annual | Arrowhead Resarch | 1 | 6/1/2010 |
| Unidym and Guardian Industries Form Partnership to Develop and Commercialize Car | Arrowhead Resarch | 1 | 5/19/2010 |
| CNT-Enabled Touch Sensitive MP-4 Players Based on Unidym's Printable CNT Fil | Arrowhead Resarch | 1 | 4/12/2010 |
| Calando, CalTech Researchers Publish Phase I Data on siRNA Cancer Drug March 22, | Arrowhead Resarch | 1 | 3/24/2010 |
| Arrowhead Research Subsidiary, Calando Pharmaceuticals, Provides First Proof of | Arrowhead Resarch | 2 | 3/22/2010 |
| FedEx And UPS The Couriers When we send stuff via a courier, which includes UPS | Telos (TLSRP) preferred | | 2/25/2010 |
| Arrowhead's Portfolio Company, Nanotope, Publishes Preclinical Data Demonstr | Arrowhead Resarch | | 2/2/2010 |
| Unidym Announces Joint Venture to Market Printable CNT Electronics in Korea SU | Arrowhead Resarch | | 2/1/2010 |
| Unidym Completes Licensing Agreements to Expand Use of its Carbon Nanotube IP in | Arrowhead Resarch | | 1/20/2010 |
| Tego Biosciences is acquired by Luna Innovations ROANOKE, Va., Dec 29, 2009 (BU | Arrowhead Resarch | | 12/29/2009 |
| Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to | Arrowhead Resarch | | 12/28/2009 |
| Arrowhead Subsidiary, Unidym, Enters into Joint Development Agreement with a Maj | Arrowhead Resarch | | 12/14/2009 |
| Rival Secures USD $137 Million Financing for TRU Process Development HENDERSON | RIVAL Technologies Inc. (RVTI) | | 12/11/2009 |
| Unidym and Nano-C Enter Exclusive License Agreement for Fullerene Derivatives Us | Arrowhead Resarch | | 12/2/2009 |
| RIVAL Orders Engineering of First TRU Process Pilot Plant HENDERSON, Nev., Dec | RIVAL Technologies Inc. (RVTI) | | 12/1/2009 |
| Rival Technologies Announces Ecopetrol Colombia Opportunity HENDERSON, Nev., No | RIVAL Technologies Inc. (RVTI) | | 11/16/2009 |
| Arrowhead Subsidiary Unidym, Inc. Enters into Third Year of Joint Development Pr | Arrowhead Resarch | | 11/11/2009 |
| Arrowhead CEO Provides Update on Company Strategy and Operations PASADENA, Cali | Arrowhead Resarch | | 11/3/2009 |
| Telos to Deliver Secure, Geomapping Imagery Visualization Solution to Hawaii Air | Telos (TLSRP) preferred | | 10/6/2009 |
| Telos ID Partners with Smartmatic to Offer Portable Biometric Enrollment Platfor | Telos (TLSRP) preferred | | 9/21/2009 |
| Arrowhead Subsidiary Calando Pharmaceuticals Enters into License Agreement with | Arrowhead Resarch | | 6/23/2009 |
| Arrowhead Subsidiary Unidym Establishes Partnership with Continental Carbon Comp | Arrowhead Resarch | | 5/11/2009 |
| joke or oxymoron ? Compliance and Ethics Telos to Fill Seat on Open Complianc | Telos (TLSRP) preferred | | 3/12/2009 |
| Calando Pharmaceuticals Publishes New Results of siRNA Delivery Using Its RONDEL | Arrowhead Resarch | | 12/8/2008 |
| Arrowhead Research (NASDAQ: ARWR) Subsidiary, Calando Pharmaceuticals, Inc., Fea | Arrowhead Resarch | | 12/5/2008 |
| November 18, 2008 Nanotech Touch-Screens Could Make You Historic Returns I notic | Arrowhead Resarch | | 11/19/2008 |
| Arrowhead CEO Provides Update on Tego Biosciences Corporation Wednesday November | Arrowhead Resarch | | 11/19/2008 |
| Arrowhead CEO Provides Update on Nanotope, Inc. Wednesday November 12, 7:00 am E | Arrowhead Resarch | | 11/12/2008 |
| Arrowhead CEO Provides Update on Majority Owned Subsidiary Unidym, Inc. Tuesday | Arrowhead Resarch | | 11/4/2008 |
| Arrowhead CEO Provides Update on Wholly Owned Subsidiary Agonn Systems, Inc. Tue | Arrowhead Resarch | | 10/28/2008 |
| Unidym Lauds Samsung Electronics' Demo of Color Carbon Nanotube-Based Electr | Arrowhead Resarch | | 10/27/2008 |
| Arrowhead Considering Selling Subsidiary Calando to Cash In On Delivery Technol | Arrowhead Resarch | | 10/24/2008 |
| Calando Pharmaceuticals Announces Completion of IT-101 Phase 1 Clinical Study Th | Arrowhead Resarch | | 10/23/2008 |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.